Pacific Biosciences Raises $100M in Series E Financing; Plans to Commercialize Sequencer in 2010

Jul 14, 2008

NEW YORK (GenomeWeb News) - Pacific Biosciences said today that it has raised $100 million in new financing that it will use to commercially develop its single-molecule DNA sequencing platform.

Hugh Martin, chairman and CEO of Pacific Biosciences, said in a statement that the financing “will enable us to surge forward with an aggressive development program” and commercialize the platform in 2010.

The Series E private equity funding came from a group composed of both new previous investors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Push for Predictive Genetic Tests

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

Gene-Editing Registry Proposed

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Sneaking Out of the Lab

Vox writes that lab mishaps involving pathogens are quite common.

This Week in Genome Biology

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.

Menu